Published online before print March 2, 2006, doi: 10.1161/01.ATV.0000215951.36219.a4
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2006 American Heart Association, Inc.
Vascular Biology |
Endothelial Dysfunction and Low-Grade Inflammation Explain Much of the Excess Cardiovascular Mortality in Individuals With Type 2 Diabetes
The Hoorn Study
From the Department of Internal Medicine, Bethesda General Hospital, Hoogeveen, the Netherlands (J.d.J., A.K); the Institute for Research in Extramural Medicine (J.M.D., P.J.K., G.N., R.J.H., L.M.B., C.D.A.S.), VU University Medical Center, Amsterdam, The Netherlands; and the Department of Internal Medicine, University Hospital Maastricht, The Netherlands (C.D.A.S.).
Correspondence to Coen D.A. Stehouwer, MD, Professor and Chair, Department of Medicine, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands. E-mail csteh{at}sint.azm.nl
Objective— The mechanisms responsible for the increased cardiovascular disease risk that accompanies type 2 diabetes (T2D) remain poorly understood. It is commonly held that endothelial dysfunction and low-grade inflammation can explain, at least in part, why deteriorating glucose tolerance is associated with cardiovascular disease. However, there is no direct evidence for this contention.
Methods and Results— In this population-based study (n=631), T2D was cross-sectionally associated with both endothelial dysfunction and low-grade inflammation, whereas impaired glucose metabolism (IGM) was associated only with low-grade inflammation. These findings were independent of other risk factors that accompany T2D or IGM. During a follow-up of 11.7 years (median; range 0.5 to 13.2 years), low-grade inflammation was associated with a greater risk of cardiovascular mortality (hazard ratio, 1.43 [95% CI, 1.17 to 1.77] per 1 SD difference). For endothelial dysfunction, the association with cardiovascular mortality was stronger in diabetic (hazard ratio, 1.87 [95% CI, 1.43 to 2.45]) than in nondiabetic individuals (hazard ratio, 1.23 [95% CI, 0.86 to 1.75]; P interaction=0.06). Finally, T2D-associated endothelial dysfunction and low-grade inflammation explained 
43% of the increase in cardiovascular mortality risk conferred by T2D.
Conclusions— These data emphasize the necessity of randomized controlled trials of strategies that aim to decrease cardiovascular disease risk by improving endothelial function and decreasing low-grade inflammation, especially for T2D patients.
Endothelial dysfunction and low-grade inflammation may explain, at least in part, the increased cardiovascular disease risk in type 2 diabetes (T2D). For endothelial dysfunction, the association with cardiovascular mortality was stronger in diabetic than in nondiabetic individuals (P interaction=0.06). T2D-associated endothelial dysfunction and low-grade inflammation explained 43% of the increase in cardiovascular mortality risk conferred by T2D.
Key Words: epidemiology • diabetes mellitus • endothelium • inflammation • mortality
This article has been cited by other articles:
 |
|
 |
|
  K. S. Stamatelopoulos, G. D. Kitas, C. M. Papamichael, E. Chryssohoou, K. Kyrkou, G. Georgiopoulos, A. Protogerou, V. F. Panoulas, A. Sandoo, N. Tentolouris, et al. Atherosclerosis in Rheumatoid Arthritis Versus Diabetes: A Comparative Study Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1702 - 1708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Goldberg Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3171 - 3182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kooy, J. de Jager, P. Lehert, D. Bets, M. G. Wulffele, A. J. M. Donker, and C. D. A. Stehouwer Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus Arch Intern Med, March 23, 2009; 169(6): 616 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. M. Reddy, K. V. Ramana, S. Srivastava, A. Bhatnagar, and S. K. Srivastava Aldose Reductase Regulates High Glucose-Induced Ectodomain Shedding of Tumor Necrosis Factor (TNF)-{alpha} via Protein Kinase C-{delta} and TNF-{alpha} Converting Enzyme in Vascular Smooth Muscle Cells Endocrinology, January 1, 2009; 150(1): 63 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Xue, Q. Qian, A. Adaikalakoteswari, N. Rabbani, R. Babaei-Jadidi, and P. J. Thornalley Activation of NF-E2-Related Factor-2 Reverses Biochemical Dysfunction of Endothelial Cells Induced by Hyperglycemia Linked to Vascular Disease Diabetes, October 1, 2008; 57(10): 2809 - 2817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Astrup, L. Tarnow, L. Pietraszek, C. G. Schalkwijk, C. D.A. Stehouwer, H.-H. Parving, and P. Rossing Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years: Association with mortality and decline of glomerular filtration rate Diabetes Care, June 1, 2008; 31(6): 1170 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Corsetti, D. Ryan, A. J. Moss, D. L. Rainwater, W. Zareba, and C. E. Sparks Glycoprotein Ib{alpha} Polymorphism T145M, Elevated Lipoprotein-Associated Phospholipase A2, and Hypertriglyceridemia Predict Risk for Recurrent Coronary Events in Diabetic Postinfarction Patients Diabetes, May 1, 2007; 56(5): 1429 - 1435. [Abstract] [Full Text] [PDF]
|
|